
Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors.
Kevin Y. Chen, PharmD, MS, BCOP, CPP, is a clinical pharmacist practitioner at the University of North Carolina (UNC) Medical Center specializing in the care of patients with thoracic malignancies and sarcoma.